Markets
markets
Luke Kawa
2/24/25

Jamie Dimon knows when to buy JPMorgan shares, and he’s “reluctant” to do so right now

When JPMorgan CEO Jamie Dimon talks about the outlook for interest rates, or the US economy, I generally don’t listen.

When he talks about his own stock? Well, then I’m rapt with attention.

In an interview with CNBC this afternoon, Dimon said the following after being asked about uses for the firm’s ample excess capital:

“But stock buyback, to me, is — you should buy back the stock when you think it’s cheap. And so we have been very reluctant to buy back stock at these prices. And we will have opportunities. But one day, we will deploy that capital in a way that’s very good for our shareholders.”

Those words speak volumes, and Dimon’s past actions regarding JPMorgan shares speak even more loudly. Back in February 2016, when the S&P 500 had fallen 14% amid fears of a hard landing in China and the potential for souring loans, particularly in the beaten-down commodities space, Dimon spent more than $25 million of his own money to make a big purchase of company stock.

That buy marked, to the day, the market bottom. And Dimon’s faith in the preeminent US financial firm may not just have coincided with that trough, but also, given his stature, helped catalyze the renewed market rally.

JPMorgan has been the worst performer in the KBW Bank Index since February 13, the day when leaked audio showed Dimon delivering an impassioned indictment of work-from-home policies. The company is also the second-largest weight in the iShares MSCI USA Momentum Factor ETF, which has gotten crushed in the last three sessions following the underwhelming outlook issued by Walmart, another large component in that ETF.

Shares were little changed on Dimon’s remarks, remaining down about 1% on the day.

More Markets

See all Markets
markets
Luke Kawa
9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.